Article
Comparison of replication competence of wild-type and lamivudine-resistant hepatitis B virus isolates from a chronic hepatitis B patient.
Virus research - 15 Aug 2018
Zhang Quan, Chen Junhao, Pan Mingjie, Liu Jingli, Liu Tingting, Zhou Yi-Hua
Abstract excerpt
In lamivudine-refractory chronic hepatitis B (CHB) patients, discontinuation of lamivudine therapy may lead to loss of lamivudine-resistant hepatitis B virus (HBV) and reappearance of wide-type HBV as dominant strains, yet the underlying mechanism remains unclear. In this study, we cloned wide-type and lamivudine-resistant HBV genomes from the sera of a CHB patient who stopped lamivudine therapy after occurrence...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
